Back

Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects

European Heart Journal - Cardiovascular Pharmacotherapy

24 April 2026
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR NURSING AND ALLIED PROFESSIONS CARDIOVASCULAR PHARMACOLOGY

Contributors

Lorenz Van der Linden
Lorenz Van der Linden

Author

University Hospitals (UZ) Leuven Leuven , Belgium

Thomas Vanassche
Thomas Vanassche

Author

University Hospitals (UZ) Leuven Leuven , Belgium

You may be interested in
thumbnail
Webinar
How to manage cancer therapy-related cardiovascular toxicity. ESC 2022 Clinical Practice Guidelines - Webinar Series
19 September 2022
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023
thumbnail
Congress Session
EHRA Consensus Paper on Antiarrhythmic Drugs (AADs)
30 March 2025
thumbnail
ESC TV Today
Episode 7: Coronary spasm - Sex differences in heart failure
16 January 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources